4.400USD-23.55%Mkt Cap: 291.14M USDP/E: —Last update: 2026-06-01
Immuneering Corporation, a late-stage oncology company, develops medicines for broad populations of cancer patients in the United States. The company develops IMM-1-104 (atebimetinib), a dual-MEK inhibitor that is in a P…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap291.14M USD
Enterprise Value220.34M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-56.02M USD
Revenue/Share—
Last Price4.400 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees55
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.31
PEG—
EV/EBITDA-3.74
EV/Revenue—
P/S—
P/B1.71
EPS (TTM)-1.06
EPS (Forward)-1.34
52W Range
1.63033% of range10.08
52W High10.08 USD
52W Low1.630 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-25.64%
ROA-24.15%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-45.34M USD
CapEx (TTM)142.23K USD
FCF Margin—
FCF Yield-11.40%
Net Debt-152.96M USD
Net Debt/EBITDA2.60
Balance Sheet
Debt/Equity0.02
Current Ratio32.45
Quick Ratio31.50
Book Value/Sh3.380 USD
Cash/Share2.422 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)17.00 USD
Target Range11.00 USD – 30.00 USD
# Analysts6
Ownership
Shares Out.64.70M
Float49.44M
Insiders17.81%
Institutions47.31%
Short Interest
Short Ratio13.1d
Short % Float20.15%
Short % Out.15.29%
Shares Short9.89M
Short (prev mo.)9.61M
Technical
SMA 505.324 (-17.4%)
SMA 2005.798 (-24.1%)
Beta0.36
S&P 52W Chg27.94%
Avg Vol (30d)1.45M
Avg Vol (10d)2.19M
Technical Indicators
RSI (14)59.4
MACD-0.0038
MACD Signal-0.0523
MACD Hist.+0.0485
BB Upper5.628 USD
BB Middle5.234 USD
BB Lower4.839 USD
BB Width15.06%
ATR (14)0.4391 USD
Vol Ratio (20d)1.54x